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Results of molecular and pathogenic studies of three different bacterial hemolysins (cytoly-
sins) are presented. These exoproteins derive from the two gram-negative bacteria Esche-
richia coli and Aeromonas hydrophila and from the gram-positive pathogen Listeria 
monocytogenes. The hemolysin of E. coli is determined by an 8-kilobase (kb) region that 
includes four clustered genes (hlyC, hlyA, hlyB, and hlyD). This hemolysin determinant 
is part either of large transmissible plasmids or of the chromosome. The genes located 
chromosomally are found predominantly in E. coli strains that can cause pyelonephritis 
and/or other extraintestinal infections. A detailed analysis of the chromosomal hly deter-
minants of one nephropathogenic E. coli strain revealed the existence of specific, large 
chromosomal insertions 75 kb and lOO kb in size that carry the hly genes but that also 
influence the expression of other virulence properties, i.e., adhesion and serum resistance. 
The direct involvement of E. coli hemolysin in virulence could be demonstrated in several 
model systems. The genetic determinants for hemolysin (cytolysin) formation in 
, A. hydrophila (aerolysin) and L. monocytogenes (listeriolysin) are less complex. Both 
cytolysins seem to be encoded by single genes, although two loci (aerB and aerC) that 
affect the expression and activity of aerolysin have been identified distal and proximal 
to the structural gene for aerolysin (aerA). Cytolysin-negative mutants of both bacteria 
were obtained by site-specific deletion and/or transposon mutagenesis. These mutants 
show a drastic reduction in the virulence of the respective bacteria. 
Synthesis of hemolysins has been reported through-
out a broad spectrum of gram-negative and gram-
positive bacterial species. The in vivo action of 
hemolysins ultimately causes physical damage to a 
variety of eukaryotic cells. Bacterial products pos-
sessing such a membrane-damaging action have been 
termed cytolysins, and a cytolytic action on eukary-
otic cells has been demonstrated for many of the 
hemolysins. The biochemical basis ofhemolysis (cy-
tolysis) varies and may either be enzymatic (e.g., the 
phospholipase of Pseudomonas aeruginosa) or non-
enzymatic (e.g., the thiol-activated cytolysins of sev-
eral gram-positive bacteria). 
The introduction of genetic techniques, especially 
recombinant- DNA techniques, has accelerated 
detailed studies of hemolysin synthesis and trans-
port in a number of bacteria. The isolation of the 
genes and their gene products, in conjunction with 
the study of animal models, has helped to elucidate 
the contribution of hemolysin to the virulence of 
hemolytic strains. The most extensive studies of 
hemolysins have been performed in Escherichia coli, 
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but progress has also been made recently in the 
genetic analysis of other hemolysins from both gram-
positive and gram-negative bacteria. Although more 
hemolytic extracellular proteins have been described 
and characterized in gram-positive than in gram-
negative bacteria, less work has been reported on the 
genetics of these hemolysins. This lack reflects the 
difficulties encountered in cloning hemolysin genes 
from gram-positive bacteria. Cloning of such genes 
in E. coli is often accompanied by problems of 
limited transport, possibly incorrect processing of 
putative precursors, and, at times, of imperfect gene 
expression. Here we describe molecular studies on 
the hemolysins (cytolysins) of three bacterial systems: 
E. coli, Aeromonas hydrophila, and Listeria 
monocytogenes. It is further shown that these cytoly-
sins represent important virulence factors. 
Results and Discussion 
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Hemolysin from Escherichia coli 
The genetics of a-hemolysin synthesis in E. coli was 
intensively studied during the past years (for review 
see [1, 2]). Hemolysin synthesis is observed mainly 
in E. coli strains that cause extraintestinal infections, 
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and the incidence of hemolytic strains is particularly 
high in E. coli strains that cause pyelonephritis. 
These strains carry the hly determinant predomi-
nantly on the chromosome, whereas many hemolytic 
, E. coli isolates from animal sources harbor plasmid-
encoded hly determinants. The chromosomal and 
the extrachromosomal hly determinants are highly 
homologous and consist of four structural genes, 
designated as hlyC, hlyA, hlyB, and hlyD [3]. These 
four hly genes are controlled by at least two 
promoters. One promoter (PhlYL) is located prox-
imal to hlyC. Transcription of hlyC, hlyA, and pos-
sibly hlyB starts from this promoter. A sequence of 
more than 400 base pairs (bp) proximal to hlyC has 
been shown to be necessary for full promoter activ-
ity in a chromosomal hly determinant [4]. The cor-
responding promoter sequence of most extrachro-
mosomal hly determinants differs considerably in 
its nucleotide composition from the chromosomal 
sequence [5, 6] and seems to be interrupted by an 
IS2 insertion at position -470 bp proximal to hlyC 
(position 1 being the first nucleotide of the hlyC 
gene) since a sequence proximal to IS2 that acts in 
the cis position is necessary for the full expression 
of the plasmid-encoded hly genes. At least three 
different phly sequences have so far been identified 
in seven hly determinants analyzed [6]. A second pro-
moter initiates the transcription of hlyD. 
The precise location of this promoter is not yet 
known. The plasmid-encoded hly determinant is 
flanked in most Hly plasmids by insertion-type ele-
ments, whereas chromosomal hly determinants may 
be located on larger chromosomal inserts (70-100 
kb) that carry short, directly repeated sequences at 
their ends [7]. Homologous recombination between 
the two direct repeats leads to deletions that remove 
these inserts precisely. The nephropathogenic E. coli 
06 strain 536 carries two such inserts of 75 kb and 
100 kb in size, both of which contain an active hly 
determinant (hlyJ and hlyJl). 1\\'0 types of sponta-
neous deletion mutants, which suffered deletions of 
either one (hlyJ or hlyJl) or both inserts (hlyJ and 
hlyJl), were obtained from this strain. The latter mu-
tant type (type I) lacks not only the hemolytic pheno-
type but also the expression of the mannose-resistant 
hemagglutination that is associated with both S-type 
fimbriae (sja) [8] and a drastic decrease in serum re-
sistance [9]. By analyzing type II mutants (hlyJ or 
hlyJl), it can be shown that serum resistance is as-
sociated with the hlyII-carrying insert. The block ex-
pression and the expression of the sja genes of the 
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hemolytic phenotype occur at the transcriptional 
level [7]. 
Type I mutants are nonvirulent when tested in sev-
eral animal models [10] and thus can be used as suit-
able hosts for reconstitution of virulence by rein-
troduction of cloned virulence genes. Hemolysin 
determinants from various origins were introduced 
with and without the sja genes in such mutants. Ta-
ble I shows that hemolysin alone exhibits toxic ef-
fects after injection of the manipulated strains into 
the mouse peritoneum or into chicken embryos. The 
level of toxicity depends on the hly determinant used 
and is, in general, higher for hly determinants that 
are of chromosomal origin than for those of extra-
chromosomal origin. The molecular cause for the 
difference in toxicity lies in the amount of extracel-
lular hemolysin expressed by the hly determinant 
(which is mainly a function of sequences located 
proximal to hlyC) and in the quality of the secreted 
hemolysin protein, which may differ in amino acid 
composition between hemolysins from various 
hemolytic E. coli strains. In addition, the serotype 
of the bacterial host seems to influence the toxic 
potential of E. coli hemolysins, as demonstrated by 
0l8:K5 Hly- mutants, wbich, in contrast with the 
06:K15 Hly- strains, exhibit only minor changes in 
toxicity after introduction of the cloned hly genes 
(table 1). 
1\\'0 hly determinants, one of chromosomal ori-
gin and the other of plasmid origin, were sequenced 
[6, 11], and the amino acid composition for the pro-
teins was deduced from the DNA sequence. All four 
hly genes exhibit an unusually high A + T content 
(1'\)60 molOJo A + T) as compared with other E. coli 
genes (on the average 50 mol% A + T). The codon 
usage for the Hly proteins also shows unusual devi-
ations from the average E. coli codon usage. Both 
lines of experimental data suggest that the hly genes 
found today in E. coli may not derive from this or-
ganism. The secreted hemolysin consists of the un-
processed hlyA product, a protein of 107 kilodalton 
(kdal). 
This protein is found in the supernatant only when 
the two hly genes Band D are actively expressed. 
In the absence of hlyC, the HlyA protein is likewise 
secreted, albeit in lower amounts, but this product 
is hemolytically inactive. This finding suggests that 
Hlye protein activates HlyA by a yet unknown mech-
anism to become hemolytically active, and that HlyB 
and HlyD function as transport proteins for HlyA. 
Neither HlyA nor the other hly gene products that 
Table 1. Virulence tests for Escherichia coli. 
Plasmid-located hly genes· 
Bacterial strain hlyX hlyC hlyA hlyB hlyD 
536 
(Hly+, Sfa+, 06) 
536-21 
(Hly-, Sfa-, 06) 
536-21 rw~~ 
(Hly-, Sfa-, 06) pANN202-312 
536-21 W&'~~#~A21 
(Hly-, Sfa-, 06) pANN202-312 - Sal/pBR 
536-21 
(Hly-, Sfa-, 06) pANN53 1 1-018 
536-21 
(Hly-, Sfa-, 06) pANN5311 - 018 - Sal/cos 
536-21 
(Hly-, Sfa-, 0.6) pANN52 1 1-06 
536-31 
(Hly-, Sfa+, 06) 
536-31 
(Hly-, Sfa+, 06) pANN202-312 
536-31 ~~ 
(Hly-, Sfa+, 06) pANN53 11-018 
536-31 
(Hly-, Sfa+, 06) pANN52 1 1-6 
764 
(Hly+, P-Fim, 018) 
764-2 
(Hly-, P·Fim, 018) 
764-2 W#~##/10"##dW#,0%1 
(Hly-, P-Fim, 018) pANN202-312 
764-2 
(Hly-, P-Fim, 018) pANN202-312 - Sal/pBR 
764-2 tw~ 
(Hly-, P-Fim, 018) pANN53 1 1-018 
764-2 
(Hly-, P-Fim, 018) pANN5311-018 - Sal/cos 
Exported 
hemolysin t (070) 
41.6 
11.1 
71.8 
26.1 
0.1 
33.8 
50.6 
71.6 
61.9 
17.6§ 
31.8 
75.8 
75.3 
Virulence 
effects; 
High 
No 
Low 
High 
High 
No 
Intermediate 
Low 
Low/ intermediate ' 
High 
Intermediate/ high 
High 
Intermediate 
Intermediate 
High 
Intermediate 
High 
• The hemolysin determinant consists of four genes, hlyC, A, B, and D. Proximal to hlyC an IS2 element and another sequence, 
hlyX, are located. The recombinant DNAs used parts derived from the plasmid pHlyl52 (filled boxes) or from the chromosomes 
of 06 and 018 strains, respectively (open boxes). 
t The amount of released hemoglobin is given relative to complete lysis of erythrocytes by absorption at 546 nm when a constant 
aJiquot of cell-free supernatant is incubated for 30 min at 37°C. 
; The virulence effects were estimated in a mouse peritonitis assay (injection of 1 x 109-4 X 10' bacteria into the mouse peritoni-
urn) and in a chicken embryo model (injection of 1 x 1Q6-1 X 109 bacteria into the allantoic cavity of chicken embryos). 
§ The amount of exported hemolysin increased by a factor of three to four in the late log phase of growth. 
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are required for the transport of hemolysin carry con-
ventional N-terminal transport signal sequences. Yet, 
there is recent evidence that HlyA carries a sequence 
for its own transport across the cytoplasmic mem-
brane, since proteins derived from fusions between 
hlyA and phoA , the latter being devoid of the trans-
port signal (by ATnphoA [12]), are transported across 
the cytoplasmic membrane when <100 amino acids 
from the N-terminal end of HlyA are fused to PhoA. 
However, the transport of these fusion proteins 
across the outer membrane cannot be accomplished 
by complementation with hlyB and hlyD, a finding 
which suggests that possible recognition sites on 
HlyA for HlyB and HlyD are located closer to the 
"HIy activity 
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C-terminal end of HlyA, as suggested by previous 
data [13], or that the transport system (HlyB and 
HlyD) is recognized only by HlyA in its intact con-
formation. 
Recent data show that extracellular hemolysin is 
extremely sensitive to lipase treatment (figure 1). 
Phospholipase A2 as well as phospholipase C rap-
idly inactivate extfa- and intracellular hemolysin 
without affecting the size of the HlyA protein (fig-
ure 1). Erythrocytes treated with these lipases are not 
lysed, nor do they become resistant to hemolysin; 
this is evidence that association of HlyA with phos-
pholipids may be essential for activity. How and 
where this association occurs remains unclear. 
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Figure 1. Sensitivity of extracellular 
hemolysin (HLY) from Escherichia coli 
to phospholipase C (PL). Hemolysin 
was prepared from the supernatant of 
E. coli 5K harboring the recombinant 
plasmid pANN202-812, which allows 
the overproduction of hemolysin deter-
mined by the plasmid pHly152 
(authors' unpublished observations). 
Treatment of erythrocytes (ERY) with 
phospholipase C does not alter the sen-
sitivity to hemolysin (upper curve, ERY 
+ PL). Addition of phospholipase C 
to erythrocytes and hemolysin leads to 
a drop in hemolytic activity that is de-
pendent on the concentration of phos-
pholipase (middle curve, ERY + PL 
+ HLY). lfeatment of hemolysin with 
increasing amounts of phospholipase 
C inactivates the hemolysin and leads 
to a drastic reduction of lysis of added 
erythrocytes (lower curve, HLY + PL 
+ ERY). Incubation with phospholi-
pase was always for 5 min at 37°C. The 
insert shows the electrophoretic mobil-
ity on PAGE of the HlyA protein (107 
kdal) without treatment (lane A), af-
ter treatment with phospholipase A2 
(lane B), and with phospholipase C 
(lane C). The slower migrating bands 
in B and C are the respective phospholi-
pases. 
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Figure 2. Physical map of the aerolysin-producing plasmid pHPC3-l. Open bars represent cloned Aeromonas hydrophila 
DNA; closed bars represent the vector ptadl. The region marked A is the structural gene for aerolysin. Regions B 
and C denote flanking regions that respectively modulate activity and expression of the aerolysin gene product. 
Hemolysin (Cytotoxin) from 
Aeromonas hydrophila (Aerolysin) 
Aeromonas hydrophila is a gram-negative bacterium 
that is capable of causing a wide range of infections 
in both healthy and immunocompromised human 
hosts. The clinical picture of aeromonal infections 
ranges from gastroenteritis to rapidly progressing 
life-threatening wound infections and septicemia. 
Many strains have been shown to elaborate various 
exotoxins, including two hemolysins (one of which 
is a cytotoxic hemolysin termed aerolysin), entero-
toxin, and proteases. 
A large body of literature implicates the cytotoxic 
hemolysin, aerolysin, as an important virulence fac-
tor. Wild-type isolates vary widely in their ability to 
produce the toxin, and toxicity assays performed 
with mice show a correlation between the amount 
of toxin produced and the rate of mortality. A re-
cent study of 686 isolates from various geographic 
locations has shown a strong correlation between 
hemolysis and enterotoxicity [14]. 
To understand the role of the toxin in Aeromonas-
associated infections, we have cloned the correspond-
ing gene. The aerolysin gene (aerA) was identified 
from a gene bank carrying DNA of a pathogenic 
A. hydrophila strain AH2 by screening for hemolytic 
activity on blood agar plates and for cytotoxicity to 
Chinese hamster ovary cells [15]. Genetic mapping 
of the cloned fragment, carried out by transposon 
mutagenesis with TnlOOO and deletion analysis with 
restriction endonucleases, has permitted us to define 
flanking regions that modulate the onset of synthe-
sis activity (aerB) and expression (aerC) of the aer-
olysin gene (aerA) (figure 2). 
While aerolysin is actively excreted in exponen-
tially growing cultures of A. hydrophila AH2, it is 
poorly transported in E. coli. The cloned aerolysin 
has been identified as a protein with an apparent mo-
lecular weight of 54 kdal in E. coli by specific label-
ing of plasmid-encoded polypeptides in a maxicell 
strain and by immunoblotting of total lysates of 
E. coli strains harboring aerA plasmids [14]. It is of 
interest that the protein produced by E. coli carry-
ing the cloned aerA (54 kdal) is larger than the pro-
tein present in culture supernatants of A. hydrophila 
AH2 (52 kdal). 
In order to characterize the aerolysin gene further 
and to evaluate the pathogenic potential of aeroly-
sin in aeromonal disease, we constructed mutants of 
A. hydrophila AH2 that carried deletions in the 
cloned genes and that failed to produce aerolysin. 
The E. coli vector pBR322 and its derivatives are 
unable to replicate stably in A. hydrophila and are 
rapidly lost by segregation (authors' unpublished 
results). Such vectors can be efficiently introduced 
into A. hydrophila when supplied with a mob func-
tion from a plasmid with a broad host range. Our 
strategy of obtaining aerolysin-negative mutants in 
A. hydrophila was therefore to introduce deleted de-
rivatives of the aerolysin gene cloned on a pBR322-
based mobilizable vector into A. hydrophila. The de-
tection of mutants required association of a selecta-
ble marker with the cloned DNA sequence. We chose 
the kanamycin-resistance gene from the transposon 
Tn903 since that gene does not carry sequences ho-
mologous to the A. hydrophila chromosome. 
We first recloned the 5.8-kb EcoRI fragment from 
pHPC3-1 (figure 2) in the mobilizable vector 
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pSUP205, producing the plasmid pHPC3-700. Sub-
sequently, 1.8 kb of aeromonal DNA sequences be-
tween the KpnI sites of pHPC3-700 were replaced 
by a 1.4-kb KpnI fragment carrying the kanamycin-
resistance gene of Tn903. The 1.8-kb aerA-aerB de-
letion present on the resulting plasmid pHPC3-702 
is a deletion-substitution, since the DNA encoding 
resistance to kanamycin was inserted at a position 
formally occupied by the deleted aerA-aerB DNA. 
E. coli recombinants harboring the resulting plas-
mid pHPC3-702 were completely devoid of both 
hemolytic and cytotoxic activities. 
The marker-exchange procedure of Ruvkun and 
Ausubel [16] was used to recombine the deletion-kan 
substitution mutation of pHPC3-702 into a spon-
taneously derived nalidixic acid-resistant mutant of 
A. hydrophila AH2 (AB3). Subsequent in vivo 
recombination and segregation produced genetic 
recombinants that had the resident aerA-aerB region 
replaced by the substitution mutation carried by 
pHPC3-702. One such recombinant was used for 
subsequent studies. 
Southern-blot hybridization was used to confirm 
the genetic structure of AB3 tox-5 (data not shown). 
Immunoblots performed with specific antibody 
directed against aerolysin showed the total absence 
of aerolysin both in cell lysates and supernatant 
fluids of AB3 tox-5. 
We next determined the LDso of both the wild-
type strain (AB3) and its isogenic aerolysin-negative 
derivative (AB3 tox-5). Intraperitoneal injection of 
mice with the parental strain AB3 showed a LDso 
of "-'5 x 107 cells, while the aerolysin-negative de-
rivative had an LDso of >1 x 109 cells. To exclude 
the possibility that unlinked mutations affecting tox-
icity had been introduced during the construction 
of AB3 tox-5, we reintroduced the wild-type aer de-
terminant on pHPC3-700 into AB3 tox-5. A double 
cross-over event leading to integration of wild-type 
aerA-aerB genes was detected by plating on blood-
agar plates. Several stable transconjugants were ob-
tained, and one such transconjugant (AB3 tox-5 rev-
1) was checked for its genetic structure by use of 
Southern hybridization and for aerolysin production 
in hemolysin and cytotoxin assays. As shown in ta-
ble 2, full toxicity was regained with the strain (AB3 
tox-5 rev-I), which had a LDso of 5 x 107 cells. These 
results clearly demonstrate the association of the 
toxin with lethality in mice and extend previous 
results obtained with wild-type isolates producing 
different amounts of aerolysin [14]. More than 800/0 
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Table 2. Effect of Aeromonas hydrophila AB3, AB3 
tox-5, and AB3 tox-5 rev-l strains on lethaIity in mice. 
No . of mice dead/ 
Strain No. of cells injected no. tested 
AB3 8 x 10" 5/ 5 
6 x 10" 9/ 9 
4 x 10" 5/5 
2 x 10" 5/ 5 
I x 10" 3/ 5 
5 x 10' 1/5 
AB3 tox-5 8 x 10" 0/5 
6 x 10" 1/9 
4 x 10" 0/ 5 
2 x 10" 0/ 5 
I x 10" 0/ 5 
5 x 10' 0/5 
AB3 tox-5 rev-I 8 x 108 5/ 5 
6 x 108 5/ 5 
4 x 10" 5/ 5 
2 x 10" 5/ 5 
I x 10" 3/ 5 
5 x 10' 215 
of the mice died within 22 h after inoculation, and 
all mice died within 30 h. Moreover, pure cultures 
of Aeromonas were obtained from the spleens and 
livers of these mice. The murine model therefore 
reflects well the rapidly progressing wound infections 
and septicemia seen with A. hydrophila infections 
in humans. 
If aerolysin is important in the pathogenesis of 
A. hydrophila disease, aerolysin should be produced 
in vivo, and its production could be indirectly ex-
amined by determining whether antibody to aeroly-
sin is produced during aeromonal infections. We 
therefore obtained serum samples from mice that had 
survived an LDso dose. Control serum samples in-
cluded those from mice injected with an LDso dose 
of the aerolysin-negative mutant AB3 tox-5 and from 
uninfected mice. The results obtained are shown in 
figure 3. No antibody to aerolysin was detected in 
the serum of uninfected mice and of mice infected 
with the aerolysin-negative mutant. A strong anti-
body response to aerolysin (and several other poly-
peptides) was obtained in mice that were infected 
with the wild-type isolate AB3. The detection of an-
tibodies to aerolysin in the serum of infected mice 
clearly shows that aerolysin is produced during the 
infection and is consistent with the hypothesis that 
the toxin is involved in the pathogenesis of A. hy-
drophila disease. 
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Figure 3. Antisera from (A) unin-
fected mice, (B) mice injected with 
strain AB3 tox-5, and (C) mice injected 
with AB3 were reacted with superna-
tant fluids from Aeromonas hydrophila 
AB3 that had been blotted after SDS-
PAGE electrophoresis. The large dif-
fuse band in A is methyl green, which 
has been used to mark the lane. The 
52-kdal protein is aerolysin. 
• 
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Cytolysin (Listeriolysin) from Listeria monocytogenes 
Listeria monocytogenes is a gram-positive, rod-
shaped bacterium that can cause severe infections 
in humans and animals. Most strains of 
L. monocytogenes are producers of a j3-hemolysin, 
termed listeriolysin. This hemolysin (cytolysin) has 
been characterized as an extracellular protein that 
belongs to the group of thiol-activated, cholesterol-
A B 
2 3 4 2 
22-
13-
9,7-
2,4-
3 
inhibited cytolysins and that cross-reacts immuno-
logically with streptolysin 0 (SW) [17]. The fact that 
this hemolytic activity, although often relatively weak 
in vitro, is possessed by clinical isolates and not or 
rarely by strains isolated from healthy carriers or 
from the environment has led to the assumption that 
hemolysin of L. monocytogenes is a virulence fac-
tor. Meaningful comparisons between virulent and 
4 5 
Figure 4. A: Agarose-gel electropho-
resis of chromosomal DNA from 
Listeria monocy togenes digested with 
EcoRI. Lane 1, BgnI-digested A phage 
DNA as molecular weight standard; 
lane 2, Hly- mutant M3; lane 3, Hly-
mutant Ml; lane 4, EcoRI-digested 
DNA of plasmid pAMl70 used as 
probe. B: Autoradiograph of Southern 
blots. Lanes 1 and 2, EcoRI-digested 
DNA of M3 and Ml, respectively, hy-
bridized with " P-Iabeled pAMl70 
(Southern blot prepared from the gel 
shown in A); lanes 3 and 4, HindIII-
digested DNA of M3 and Ml, respec-
tively, hybridized with " P-Iabeled 
pAMl70; lane 5, EcoRI-digested 
pAMl70 hybridized with 32P-Iabeled 
pAMl70. 
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avirulent strains have so far been hampered by the 
fact that the genetic backgrounds of such wild-type 
strains are unclear and probably divergent with re-
spect to several different determinants. 
Moreover, there is circumstantial evidence that 
more than one type of listeriolysin may exist in strains 
of Listeria. A recent study described by Parrisius et 
al. [18] has shown that only Listeria ivanovii and two 
of 26 L. monocytogenes strains of various sero-
groups secrete a hemolysin that cross-reacts on im-
munoblots with SLO antibody. 
The role of listeriolysin as a virulence factor was 
demonstrated by inactivating the genetic determinant 
essential for this protein in L. monocytogenes (Mac-
kaness strain serotype 112a) by inserting the tetra-
cycline-resistance transposon Tn916 into L. mono-
cytogenes DNA (authors' unpublished observations, 
and P. Metz, personal communication). The trans-
poson was transferred by means of conjugation of 
a streptomycin-resistant L. monocytogenes recipient 
Figure 5. SDS-PAGE of extracellu-
lar proteins produced by transposon-
bearing Listeria monocytogenes. A: 
Lanes 1 and 3, wild-type strain grown 
overnight in brain-heart infusion and 
tryptic soy broth, respectively; lanes 2 
and 4, M3 grown overnight in brain-
heart infusion and tryptic soy broth, 
respectively. B: Hly- mutant Ml grown 
overnight in brain-heart infusion broth. 
Arrow indicates the position of the pre-
sumed truncated listeriolysin. 
A 
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strain with Streptococcus jaecalis CGllO on mem-
brane filters [19]. Among the tetracycline-resistant 
transconjugants, mutants that had lost hemolytic ac-
tivity were detected. Results of hybridization studies 
with Tn916 DNA as a probe indicate that the trans-
poson is present on a single chromosomal EcoRI 
fragment and two HindIII fragments in the non-
hemolytic transposon mutants (figure 4). This find-
ing suggests that a single transposition event leads 
to the loss of the hemolytic phenotype, since Tn916 
itself contains one HindIII site but no EcoRI site. 
Preliminary evidence indicates that the transposition 
of Tn916 in these mutants occurs directly in the struc-
tural gene for listeriolysin and not in a regulatory 
site influencing hemolysin synthesis and possibly 
other virulence properties as well. Analysis of the 
extracellular proteins from supernatants of wild-type 
L. monocytogenes 1I2a and of Tn916 Hly- mutants 
indicates the loss of a single major protein of 60 kdal, 
apparently the listeriolysin (figure 5). In one type of 
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these mutants, a smaller protein of apparent molec-
ular size 49 kdal appears instead of the 60 kdal pro-
tein, probably representing a truncated listeriolysin 
protein (figure 5)t The size of the HindIII fragments 
hybridizing with the 1h916 DNA probe in the two 
types of nonhemolytic mutants (with and without 
the truncated protein) suggests that Tn916 has been 
in each case inserted in chromosomal sites that were 
only about 1 kb apart. This is consistent with the 
idea that, in the one mutant type, Tn916 has been 
inserted in a site close to the 5' end of the listerioly-
sin gene, thus generating no, or a very small, trun-
cated listeriolysin protein, whereas in the second mu-
tant type, the insertion occurred in a site 1 kb more 
distal, generating the 49-kdal truncated protein. 
After iv injection of bacteria of the wild-type 
(Mackaness strain) into mice, the course of infec-
tion previously described by Mackaness [20] for ex-
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perimental infections of mice with virulent 
L. monocytogenes was observed. The number of 
bacteria isolated from the spleens of the animals in-
creased after infection, reached a peak between the 
third and fourth day after infection, and then 
declined (figure 6). The number of bacteria isolated 
from the spleens of the animals 3 days after infec-
tion was 50 times higher than that present in the in-
oculum. Infection by iv injection of the Tetr , Hly+ 
transposon-bearing wild-type strain (wild-type with 
respect to hemolysin production) resulted in a simi-
lar pattern of bacterial multiplication within the 
animals, although the extent of multiplication was 
somewhat lower than that observed in the case of 
the parental Mackaness strain, and a 13-fold increase 
was observed. Intravenous injection of the TeF, 
Hly- mutant bacteria, however, was not followed by 
multiplication of the bacteria in the animals; instead, 
6 
Figure 6. Bacterial counts per spleen 
Mackaness 1, 3, and 6 days after intravenously in-
duced infection. Infection dosages were 
1.4 X HP, 2.7 X HP, and 3.2 X 1Q3 
of the Mackaness, wild-type (WT), and 
M3 strains, respectively. The numbers 
are means from four or five animals. 
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the numbers of bacteria isolated from the spleen 
declined sharply after their introduction, and, as 
soon as 1 day after their introduction, the bacteria 
were virtually eliminated from the animals (figure 
6). The few bacteria that could be isolated from the 
spleens were resistant to tetracycline and were non-
hemolytic. Similar results were observed in the ex-
perimental infections of mice by other Hly- mutants 
and randomly selected Hly+ transconjugants pro-
duced from different crosses. 
The infection dose of Hly- bacteria that was used 
in these experiments (3.1 X 103 bacteria) is unlikely 
to contain any Hly+ revertants, since the average 
reversion rate in vitro is 10-4. We expected that if such 
revertants were generated they would regain their 
ability to multiply within the animals. Moreover, on 
the basis of the in vitro data, we expected that most 
of these revertants would lose resistance to tetracy-
Figure 7. Bacterial counts per spleen 
1, 3, and 6 days after intravenously in-
duced infection. Infection dosages were 
2.7 x W, 2.7 x HP, and 1.4 x 10· 
for the Mackaness, wild-type (Wn and 
M3 strains, respectively. 
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cline. To test these expectations, we repeated the ex-
perimental infections of mice with the three strains 
(Mackaness strain; Tetr, Hly+ strain W1; and Tetr, 
Hly- strain M3), using standard sublethal doses of 
the hemolytic strains but three orders of magnitude 
more bacteria of the Hly- mutant (1.3 X 106 ) (figure 
7). The multiplication pattern of the hemolytic 
strains was similar to that observed earlier. The bac-
teria isolated from the spleens of the animals infected 
with WT strain were all Hly+, and similar numbers 
were isolated on media with or without tetracycline, 
an observation suggesting that the bacteria main-
tained their resistance to tetracycline in vivo and that 
loss of the transposon had not occurred. Most of 
the bacteria isolated from the animals that had been 
infected with the Hly- strain M3, however, were 
hemolytic and sensitive to tetracycline. Such bacte-
ria represented 40010, 86%, and 100% of all those 
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that were isolated 1, 3, and 6 days after infection, 
respectively. The Hly+, TetS bacteria were apparently 
revertants that had lost the transposon and regained 
the hemolytic phenotype along with the ability to 
multiply within the animals. Only a small fraction 
of the bacteria isolated from these animals were still 
Hly-, a finding which suggests that even when in-
jected in high dosages the Hly- bacteria were unable 
to multiply within the animals and were rapidly elim-
inated. These data strongly suggest that the hemoly-
sin (listeriolysin) of L. monocytogenes is an essen-
tial virulence factor. 
Conclusions 
The three virulent bacteria described in this study, 
E. coli, A. hydrophila, and L. monocytogenes, have 
in common the potential for producing extracellu-
lar hemolytic toxins. The complexity of the genetic 
determinants encoding these hemolysins (cytolysins) 
and the physical and biochemical properties of the 
corresponding exoproteins are different. Neverthe-
less, each represents a potent virulence factor, since 
its loss reduces drastically the virulence of the respec-
tive bacterial strain. The precise function of these 
cytolysins in the process of infection remains to be 
defined. 
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